Literature DB >> 20697105

Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser.

N C-C Yang1, M-J Lee, C-C Chao, Y-T Chuang, W-M Lin, M-F Chang, P-C Hsieh, H-W Kan, Y-H Lin, C-C Yang, M-J Chiu, H-H Liou, S-T Hsieh.   

Abstract

OBJECTIVE: Familial amyloid polyneuropathy (FAP) due to amyloidogenic transthyretin (TTR) is often associated with impairment of thermonociceptive functions. This study investigated skin innervation and its clinical significance in genetically defined FAP due to a hot-spot Ala97Ser TTR mutation (Ala97Ser).
METHODS: Skin biopsies were performed on the distal leg of patients with Ala97Ser, and intraepidermal nerve fiber (IENF) densities were quantified.
RESULTS: There were 19 unrelated patients with Ala97Ser manifesting a late-onset (59.47 +/- 5.70 years) generalized neuropathy with disabling motor, sensory, and autonomic symptoms. Against a background of a slowly progressive course, 7 patients (36.8%) exhibited additional rapid declines in neurologic deficits, which were associated with elevation of the protein content in the CSF (p < 0.001). The IENF density was markedly reduced in Ala97Ser patients compared to age- and gender-matched controls (0.99 +/- 1.11 vs 8.31 +/- 2.87 fibers/mm, p < 0.001). Skin denervation was present in all patients and was lower in patients with a higher disability grade (0.17 +/- 0.26 vs 1.37 +/- 1.16 fibers/mm, p = 0.003). Albuminocytologic dissociation in the CSF was observed in 14 patients (73.7%), and the IENF density was negatively correlated with the CSF protein concentration (p = 0.015).
CONCLUSIONS: Skin denervation was common in Ala97Ser, and degeneration of cutaneous nerve terminals was correlated with the severity of clinical phenotypes and the level of CSF protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697105     DOI: 10.1212/WNL.0b013e3181ec7fda

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Amyloid neuropathies.

Authors:  Susan C Shin; Jessica Robinson-Papp
Journal:  Mt Sinai J Med       Date:  2012 Nov-Dec

Review 2.  FAP neuropathy and emerging treatments.

Authors:  David Adams; Marie Théaudin; Cecile Cauquil; Vincent Algalarrondo; Michel Slama
Journal:  Curr Neurol Neurosci Rep       Date:  2014-03       Impact factor: 5.081

3.  Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?

Authors:  Adam J Loavenbruck; Wolfgang Singer; Michelle L Mauermann; Paola Sandroni; P James B Dyck; Morie Gertz; Christopher J Klein; Phillip A Low
Journal:  Ann Neurol       Date:  2016-07-25       Impact factor: 10.422

4.  A Missense Variant p.Ala117Ser in the Transthyretin Gene of a Han Chinese Family with Familial Amyloid Polyneuropathy.

Authors:  Qian Chen; Lamei Yuan; Xiong Deng; Zhijian Yang; Shengwang Zhang; Sheng Deng; Hongwei Lu; Hao Deng
Journal:  Mol Neurobiol       Date:  2017-07-31       Impact factor: 5.590

5.  Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.

Authors:  Nath Pasutharnchat; Chamaiporn Taychargumpoo; Yongkasem Vorasettakarnkij; Jakkrit Amornvit
Journal:  BMC Neurol       Date:  2021-05-22       Impact factor: 2.474

6.  Tyr78Phe Transthyretin Mutation with Predominant Motor Neuropathy as the Initial Presentation.

Authors:  Giulietta Riboldi; Roberto Del Bo; Michela Ranieri; Francesca Magri; Monica Sciacco; Maurizio Moggio; Nereo Bresolin; Stefania Corti; Giacomo P Comi
Journal:  Case Rep Neurol       Date:  2011-02-23

7.  Neuromuscular abnormality and autonomic dysfunction in patients with cerebrotendinous xanthomatosis.

Authors:  Shu-Fang Chen; Nai-Wen Tsai; Chung-Chih Chang; Cheng-Hsien Lu; Chi-Ren Huang; Yao-Chung Chuang; Wen-Neng Chang
Journal:  BMC Neurol       Date:  2011-05-31       Impact factor: 2.474

8.  Effect of glycemic control on sudomotor denervation in type 2 diabetes.

Authors:  Kai-Ren Luo; Chi-Chao Chao; Paul-Chen Hsieh; June-Horng Lue; Sung-Tsang Hsieh
Journal:  Diabetes Care       Date:  2012-02-01       Impact factor: 19.112

9.  Familial amyloidotic polyneuropathy: current and emerging treatment options for transthyretin-mediated amyloidosis.

Authors:  Ernst Hund
Journal:  Appl Clin Genet       Date:  2012-06-18

10.  The Temporal Profiles of Changes in Nerve Excitability Indices in Familial Amyloid Polyneuropathy.

Authors:  Hsing-Jung Lai; Ya-Wen Chiang; Chih-Chao Yang; Sung-Tsang Hsieh; Chi-Chao Chao; Ming-Jen Lee; Chung-Chin Kuo
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.